Label: THERAFLEX ADVANCE (ibuprofen, glucosamine sulfate, and chondroitin sulfate- bovine tablet

  • NDC Code(s): 61841-152-12, 61841-152-72
  • Packager: Bayer HealthCare LLC.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Export only

Drug Label Information

Updated January 10, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • ACTIVE INGREDIENT

    Active ingredients (in each capsule)Purposes
    Glucosamine Sulfate 250 mgDietary Supplement
    Chondroitin Sulfate 200 mgDietary Supplement
    Ibuprofen 100 mgAnalgesic
  • Uses

    • temporarily relieves minor aches and pains associated with
      • backache
      • arthritis.
  • Warnings

    Allergy alert

    Ibuprofen may cause a severe allergic reaction wich may include:

    • hives
    • facial swelling
    • asthma (wheezing)
    • shock.

    Alcohol warning

    If you consume 3 or more alcoholic drinks every day, ask your doctor whether you should take ibuprofen or other pain relieves/fever reducers. Ibuprofen may cause stomach bleeding.

    Do not use

    • if you have ever had an allergic reaction to any other pain reliever/fever reducer.

    When using this product

    • take with food or milk if stomach upset occurs.

    I f pregnant or breast-feeding, ask a health professional before use.

    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

    It is especially important not to use ibuprofen during the last 3 months of pregnancy unless specifically directed to do so by a doctor because it may cause problems in the unborn child or c omplications during delivery.

  • Directions

    Adults

    Take 1 capsule every 4 to 6 hours while symptoms persist. If pain or fever does not respond to 1 capsule, 2 capsules may be used, but do not exceed 6 capsules in 24 hours, unless directed by a doctor. The smallest effective dose should be used.

    Children

    Do not give this product to children under 12 unless directed by a doctor.

    Do not exceed recommended dose.

  • Other information

    • store at room temperature, USP.
  • Inactive ingredients

    Corn Starch, Crospovidone, Gelatin, Magnesium Stearate, Microcrystalline Cellulose, Polyvinylpyrrolidone, Pregelatinized Starch, Silica, Sodium Starch Glycolate, Stearic Acid, Titanium Dioxide, FD&C Blue#1 Lake.

  • PRINCIPAL DISPLAY PANEL - 60 Capsule Bottle Carton

    THERAFLEX™

    ADVANCE

    60 CAPSULES

    Ibuprofen 100 mg

    Glucosamine Sulfate 250 mg

    Chondroitin Sulfate 200 mg

    Carton 60 count

  • INGREDIENTS AND APPEARANCE
    THERAFLEX ADVANCE 
    ibuprofen, glucosamine sulfate, and chondroitin sulfate (bovine) tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:61841-152
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    IBUPROFEN (UNII: WK2XYI10QM) (IBUPROFEN - UNII:WK2XYI10QM) IBUPROFEN100 mg
    GLUCOSAMINE SULFATE (UNII: 1FW7WLR731) (GLUCOSAMINE - UNII:N08U5BOQ1K) GLUCOSAMINE SULFATE250 mg
    CHONDROITIN SULFATE (BOVINE) (UNII: 6IC1M3OG5Z) (CONDOLIASE - UNII:7SI2UZG934) CHONDROITIN SULFATE (BOVINE)200 mg
    Inactive Ingredients
    Ingredient NameStrength
    STARCH, CORN (UNII: O8232NY3SJ)  
    CROSPOVIDONE (UNII: 68401960MK)  
    GELATIN (UNII: 2G86QN327L)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
    Product Characteristics
    Colorblue (Blue opaque) Scoreno score
    ShapeOVALSize22mm
    FlavorImprint Code Theraflex;Advance
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:61841-152-721 in 1 CARTON12/11/2014
    160 in 1 BOTTLE; Type 0: Not a Combination Product
    2NDC:61841-152-121 in 1 CARTON12/11/2014
    2120 in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    Export only12/11/2014
    Labeler - Bayer HealthCare LLC. (785159372)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!